… Octave has developed a precision-care platform for multiple sclerosis that includes a custom biomarker assay … Study Design: Octave has developed a custom assay panel for multiple sclerosis called the MS Disease Activity test. In … signatures with relevant endpoints and employing a systems biology approach to corroborating pathophysiology. …

… Systemic administration of erythropoietin (EPO) has been … in animal models of stroke, epilepsy, head injury and multiple sclerosis (MS). It is has been hypothesized that … of the present application is to determine whether systemic administration of EPO reduces dopamine neuron loss …

… Judith diagnosed this patient with a rare presentation of multiple system atrophy (MSA), a disease related to Parkinson’s. The …

… (PD). However, achieving reliable, chronic central nervous system (the brain and spinal cord) delivery for molecules, … peripheral tissue levels will be measured and mapped using multiple techniques. In summary, we will comprehensively … will allow us to obtain critical, quantitative central and systemic distribution data for intranasally-applied …

… bidirectional control of defined brain circuits in intact systems.  Project Description: We will use technical … in a less advanced model; tunability (so it recapitulates multiple stages of the disease from mild to advanced in the …

… NeuroDerm Ltd. is developing a novel delivery system of levodopa for the treatment of Parkinson's disease. … solution for patients. NeuroDerm's new transdermal delivery system, which is designed to achieve a constant level of … toxicity study and an acute local irritation study in multiple preclinical models, NeuroDerm is planning to …